Clazakizumab
N/A
Report date: 2026/04/10 20:01:49
Base Information
Drug NameClazakizumab
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[19]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[42]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAlder Biopharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesCsl BehringEli Lilly And CompanyVitaeris Inc +[7]
Inactive CompaniesColumbia UniversityMedical University Of Vienna
Active Indications +[9]
Inactive Indications +[10]